Quotes About Patients

As a physician, I treated hundreds of patients who needed long-term care, including ones with Alzheimer's.

Less than 1 percent of the patients treated are alive at the end of five years.

Hospitals feel like they need to increase prices to make up for treating patients that don't pay their bills or that are not having insurance supporting them.

That made me think I could contribute more to society by looking at people on the autopsy table and feeding back the findings so that lots of people could benefit, rather than just treating patients one at a time.

Probably most dying patients, even when suffering greatly, would choose to live as long as possible. That courage and grace should be protected and honored, and we should put every effort into treating their symptoms.

We know how to stop Ebola: by isolating and treating patients, tracing and monitoring their contacts, and breaking the chains of transmission.

There is an enormous amount of options that a physician can provide today, right down from curing patients, treating patients, or providing patients with psychic solace or pain relief. So, in fact, the gamut of medical intervention is enormous.

I'm not a psychiatrist. I'm not treating patients.

People and organizations other than doctors increasingly are assuming power to decide which medications to prescribe or procedures to undertake. More and more, decisions about personal healthcare are no longer made by the treating physicians in consultation with their patients, and based on the doctors' expertise.

I think the way we think about cancer, the way we treat cancer, has dramatically changed in the last century. There is an enormous amount of options that a physician can provide today, right down from curing patients, treating patients or providing patients with psychic solace or pain relief.

Scientists have established huge numbers of links between particular diseases and snippets of DNA, but in the great majority of cases, this has not yet been translated into treatments that can help cure patients. These treatments will come - tomorrow, or the day after.

Named after four activists and their families who fought for its passage, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 establishes a new pathway for access to unapproved, investigational treatments. These four Americans fought for the Right to Try because they didn't want to give up.

One reason for high health care costs is that patients fail to follow their treatment regimen.

There are no bona fide treatments available for embryonic stem cells. There is nothing in the laboratory, and there is certainly nothing in the clinics available to patients.

Doctors and patients need as much data as possible to make an informed decision about what treatment is best.

The treatment of patients with contaminated blood has been described as one of the most tragic episodes in the history of the NHS.

Patients with fatal diseases are fighting for their lives every day while real, meaningful, life-extending treatments sit on the shelf just beyond their reach.

In fast moving fields like cancer, where doctors tailor treatments based on evidence that's constantly evolving, two years can be an eternity of waiting to learn about important science. For some patients, that interval can be fatal.

There was never a need to call the Army in Mumbai. I am proud of the administration which rose to the challenge and set up jumbo field hospitals for treatment of coronavirus patients in the city.

As an emergency physician, I have seen my patients forgo needed treatment because they are afraid they will lose their jobs.

While an increasing number of cancer treatment centers have begun offering post-treatment care plans and support groups to help patients navigate these challenges, many patients continue to fall through the cracks.

Hospice is such a tremendous thing. Patients seem to reach an inner peace.

For me, I think that there's a lot missing from the recovery or the post-diagnosis side of treating patients. Once the diagnosis is made, I feel that care drops off tremendously, even though it is precisely the time that a patient needs help the most, even if they are not verbalizing it.

Once an effective drug is approved to treat a deadly condition, introducing a second drug to treat the same disease can be hard. It's tough to recruit patients with a debilitating disease for a clinical trial when a proven medicine is already available.